HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81
about
sameAs
TGF-β signaling via TAK1 pathway: role in kidney fibrosisConcerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/NeuProtein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cellsAn integrated approach for identifying wrongly labelled samples when performing classification in microarray dataInduction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.Transforming growth factor beta-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone beta-subunit expression.COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer.Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis.When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene.TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancersTGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.Mechanisms and markers of carcinogenesis and neoplastic progression.ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.ETS transcription factor ERG cooperates with histone demethylase KDM4A.14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.Signaling cross-talk between TGF-beta/BMP and other pathways.Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancerTranscription factor ETV1 is essential for rapid conduction in the heart.Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.HER2 mRNA status contributes to the discrepancy between gene amplification and protein overexpression in gastric cancer.Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.Upregulation of PSMD10 caused by the JMJD2A histone demethylase.Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.The role of TGF-β/SMAD4 signaling in cancer.Grainyhead-like 2 (GRHL2) knockout abolishes oral cancer development through reciprocal regulation of the MAP kinase and TGF-β signaling pathways.
P2860
Q26824337-7B0D8AD7-EA2A-4D3E-8E8C-68AB1346C149Q28241103-51A804AE-81B0-4B86-A567-4B6EC2F083B3Q30439818-CE77AE05-A795-4CF5-ABD5-DD1B1627BB6DQ30574057-7442AACE-F5A3-45DB-A60D-3D66AAD7C1DBQ33507490-BB3F7C38-D269-45C2-8E96-13FCB7800EA6Q33757981-58706EB8-F198-448E-B181-66EB559582F8Q34155238-6E1FFF64-01DC-45B1-9F3B-DC18B2BE9FD6Q34521619-4C88A37F-6F45-4D46-BEBC-7298AD0F810FQ34793617-BA66EA56-96E9-427D-8258-7353CD1C3ACCQ35221840-1BC53963-436E-4C62-8DE8-AA7821B83997Q35237824-45311500-7A63-4619-B376-48ED7F812201Q35803226-57899E1D-9A2A-476D-8696-8A2D03A3F5BDQ35996105-00E95450-E522-4AD8-9611-9EE8DC364AC0Q36078799-90D60C97-429F-4B9B-B0DA-F54155FEB7E0Q36098453-891AB75D-8B9D-4950-8954-57C228DB84B2Q36210115-5F8F0D63-19C3-4CA1-A274-1FBF7A1BC804Q36213724-3282BF2C-F772-44CB-962C-84D93F8C9D91Q36273391-56CBDA8C-9584-4C61-A2E7-37475B486387Q36388955-496D2A9E-6663-4018-BCB5-38709E45C19FQ36468657-AB05962F-B2D1-4AC4-8FB1-A4B039973264Q36515134-90014890-AAEE-4048-9FEE-43B98BEDC771Q36645553-1468659D-C137-4C91-B089-274554D923EAQ36908878-C91F5009-5860-4240-B935-6D78AF2F47BDQ37100125-9906418B-307F-494E-9A33-A74EA1CB56F8Q37323342-7F94EF01-D328-4B63-B359-88843BC7EC35Q37372277-7FAE38E9-5265-4B8A-B555-FDEECAC03253Q37401513-DDC08B51-CAA7-47F4-A03B-5A2CE9293D83Q37452234-F491C9A7-2F37-4882-9718-DA24A958E28DQ37832528-17505BC5-0DBC-4AC6-9A0D-B8791BB0079DQ38329840-ADE383BA-5658-44BD-A8EC-E69564393F68Q39005862-B5DD88F9-4B2B-45AF-BEF1-E9DAFCECCCB8Q39067548-93E9DE7F-C2BC-4257-A27C-0E36AC9A6B34Q39362468-AC76D8CD-F266-4026-91A1-A175A093C887Q39652309-754A44A3-D512-4E4E-B098-0F90F37DA309Q41615123-36337DDB-74DF-4C85-9186-D106D4D71035Q42444492-0109D5C3-48FF-4288-9AC4-F4A6947A9EC2Q46460003-89DBC195-563A-430B-A2B4-8442909962E5Q49378728-EE799945-E050-40AC-9279-1C49FC34CA57Q52688883-6B147F9C-A740-4DF7-BB95-E6114E5DD19FQ54111743-FF462DAE-7773-4253-956E-FCCFD9AC483E
P2860
HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@ast
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@en
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@nl
type
label
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@ast
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@en
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@nl
prefLabel
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@ast
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@en
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@nl
P2093
P2860
P3181
P356
P1476
HER2/Neu- and TAK1-mediated up ...... Smad7 via the ETS protein ER81
@en
P2093
Andrea Mariani
Ralf Janknecht
Sean C Dowdy
P2860
P304
P3181
P356
10.1074/JBC.M307202200
P407
P577
2003-11-07T00:00:00Z